In Tower MSA Partners’ last post, How Tower Reduced Conditional Payments to $0, we explained how Tower reduced Medicare conditional payments to zero through detailed review and accurate documentation. This month, we focus on a case where an amended review dramatically changed the outcome of an already CMS-approved MSA. A payer requested help after receiving an unexpectedly high counter-higher from CMS. Through an amended review supported by updated medical records and clinical oversight, Tower corrected outdated projections and reduced the MSA by $101,312. This case shows how persistence and accuracy create better settlement outcomes.

Identifying the Problem

After an MSA had been submitted and approved by CMS, new medical records revealed important changes in the claimant’s treatment plan. Several medications had been discontinued, therapy frequency had decreased, and previously projected diagnostic testing was no longer recommended. As a result, the approved allocation no longer reflected the claimant’s current treatment needs and overstated projected future medical costs.

The allocation no longer aligned with the claimant’s current medical condition or ongoing treatment plan. Moving forward with settlement based on outdated projections would have resulted in funding medical expenses that were no longer supported by the available clinical evidence. The payer needed an amended review to ensure the MSA accurately reflected current medical.

Turning New Medical Evidence Into $101K in Savings

Tower MSA Partners conducted a comprehensive amended review to evaluate the newly available medical information and determine its impact on future medical cost projections.

The clinical team analyzed updated medical records, treatment histories, prescription information, and provider recommendations. During the review, several medications included in the original allocation were confirmed as discontinued and no longer medically necessary. Therapy projections were adjusted to reflect the claimant’s current treatment frequency, and future diagnostic testing recommendations were updated based on the most recent provider documentation.

Using this information, Tower prepared an Amended Review Medicare Set Aside allocation supported by detailed clinical rationale and updated medical evidence. The amended submission clearly demonstrated why the original projections no longer reflected the claimant’s current treatment needs and how the revised allocation more accurately represented future medical exposure.

CMS reviewed the amended Medicare Set Aside submission and accepted the updated allocation, resulting in a reduction of $101,312.

Outcome

• MSA Reduction: $101,312
• Strategy: Amended Review
• Key Findings: Discontinued medications, reduced therapy frequency, and updated diagnostic recommendations
• CMS Result: Revised allocation accepted
• Impact: More accurate funding and lower settlement costs

Collaboration and Communication

Successful amended reviews require more than updated medical records. They also depend on clear communication among stakeholders involved in the settlement process.

Tower MSA Partners worked closely with the claims professional to review the updated treatment information and ensure the rationale behind each amendment was thoroughly documented. When necessary, providers and defense counsel were consulted to verify treatment changes and eliminate potential discrepancies before resubmission.

This collaborative approach helped streamline the review process and provided CMS with a well-supported allocation backed by current medical evidence. Because the documentation was complete and clearly explained, CMS accepted the revised allocation without requesting additional information.

Why Amended Reviews Matter

Workers’ compensation claims are dynamic. Treatment plans change, medications are discontinued, and providers adjust recommendations based on a claimant’s progress. When those changes occur after an MSA has been prepared or submitted, failing to update the allocation can result in unnecessary funding and inflated settlement costs.

Amended reviews help ensure that Medicare Set Aside allocations remain accurate, defensible, and aligned with current medical evidence. By incorporating updated treatment information before settlement, payers can avoid overfunding future medical expenses while maintaining compliance with CMS requirements.

The amended review identified treatment projections that no longer reflected the claimant’s current medical status. Without the review, the payer would have funded more than $101,000 in projected medical costs that were no longer supported by the treatment record.

Key Takeaways

• Amended reviews help ensure Medicare Set Aside allocations reflect current medical necessity.
• Updated medical records can reveal opportunities to reduce future medical cost projections.
• Discontinued medications and changes in treatment frequency can have a significant impact on MSA allocations.
• CMS accepts amended submissions when the changes are supported by credible medical evidence and documentation.
• Proactive clinical oversight helped reduce this allocation by $101,312 while maintaining compliance and settlement readiness.

Frequently Asked Questions About Amended Reviews